Dian Diagnostics GroupLtd Balance Sheet Health
Financial Health criteria checks 5/6
Dian Diagnostics GroupLtd has a total shareholder equity of CN¥9.5B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 39.9%. Its total assets and total liabilities are CN¥17.1B and CN¥7.6B respectively. Dian Diagnostics GroupLtd's EBIT is CN¥406.9M making its interest coverage ratio 2.4. It has cash and short-term investments of CN¥1.7B.
Key information
39.9%
Debt to equity ratio
CN¥3.78b
Debt
| Interest coverage ratio | 2.4x |
| Cash | CN¥1.73b |
| Equity | CN¥9.48b |
| Total liabilities | CN¥7.60b |
| Total assets | CN¥17.08b |
Recent financial health updates
Recent updates
Dian Diagnostics Group Co.,Ltd.'s (SZSE:300244) Shares Bounce 37% But Its Business Still Trails The Industry
Oct 04
Dian Diagnostics Group Co.,Ltd. (SZSE:300244) Looks Inexpensive But Perhaps Not Attractive Enough
Aug 20Returns On Capital Signal Tricky Times Ahead For Dian Diagnostics GroupLtd (SZSE:300244)
Jul 12Dian Diagnostics GroupLtd (SZSE:300244) Will Pay A Smaller Dividend Than Last Year
Jun 10Dian Diagnostics GroupLtd (SZSE:300244) Seems To Use Debt Quite Sensibly
May 24Dian Diagnostics Group Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Apr 30Investors Holding Back On Dian Diagnostics Group Co.,Ltd. (SZSE:300244)
Apr 22Financial Position Analysis
Short Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its short term liabilities (CN¥4.9B).
Long Term Liabilities: 300244's short term assets (CN¥12.8B) exceed its long term liabilities (CN¥2.7B).
Debt to Equity History and Analysis
Debt Level: 300244's net debt to equity ratio (21.7%) is considered satisfactory.
Reducing Debt: 300244's debt to equity ratio has reduced from 63.2% to 39.9% over the past 5 years.
Debt Coverage: 300244's debt is well covered by operating cash flow (42.6%).
Interest Coverage: 300244's interest payments on its debt are not well covered by EBIT (2.4x coverage).